Watch

ANABAnaptysBio, Inc.

Healthcare · Biotechnology · small-cap ($1.5B)
-21.7%
from rolling 252-day high of $72.36 set 2026-05-05 · 107d ago
Current
$56.69
Decline depth
-21.7%
Decline σ
2.4σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$ANAB landed on the list 2026-05-28, down 22.2% from its 52-week high that day — now down -21.7%.

It has clawed back 1.0 percentage points off that level. It bottomed 31.4% below that high along the way.

Decline from the 52-week high as it stood on 2026-05-28 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ANAB qualifies for the Watch on decline depth.

Decline depth
-21.7%
From rolling 252-day high of $72.36, 107d ago. Past the 20% Watch threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.4σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (2.73% per day).

The structural read

What price action says about ANAB.

ANAB qualifies for the Watch on decline depth — down -21.7% from its rolling 252-day high.

Earnings on file: 2026-05-12. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about ANAB

What people ask.

Why is ANAB on Broken Stocks?

ANAB qualifies for the Watch on decline depth. It is down -21.7% from its rolling 252-day high of $72.36, set on 2026-05-05 — 107d ago.

Is ANAB a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. ANAB is down -21.7% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is ANAB a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ANAB trading inside its 52-week range?

At $56.69, ANAB sits 74.3% of the way from its 52-week low ($11.40) to its 52-week high ($72.36). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ANAB been declining?

The current 21.7% decline accrued over 107d, which annualizes to roughly -74.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ANAB compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 35 Amber, 38 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — ANAB's decline is shallower than the sector median.

Does ANAB's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-12) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.